ArticleChina CDC weekly2020
National Alveolar Echinococcosis Distribution - China, 2012-2016.
Article in China CDC weekly, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Alveolar Echinococcosis in the Early 2020s: A Systematic Review.Pathogens (Basel, Switzerland) · 2026Pooled it
- Imaging mass cytometry of the immune microenvironment in alveolar echinococcosis.Frontiers in cellular and infection microbiology · 2026Article
- Clinical confirmation of an infection with Echinococcus multilocularis (Mongolian genotype): first case report of human alveolar echinococcosis in Inner Mongolia, China.Infectious diseases of poverty · 2025Article
- Developing a geographical-meteorological indicator system and evaluating prediction models for alveolar echinococcosis in China.Journal of exposure science & environmental epidemiology · 2025Article
- Analysis and prediction of the incidence temporal trends of echinococcosis in China from 2010 to 2021.Scientific reports · 2025Article
- Article
- Infection of sheep by Echinococcus multilocularis in Gansu, China: evidence from mitochondrial and nuclear DNA analysis.Infectious diseases of poverty · 2023Article
- A multi-epitope vaccine GILE againstFrontiers in immunology · 2022Article
- Assessment of risk, landscape epidemiology and management strategies to combat alveolar echinococcosis in the rural communities of Hunza, Pakistan.Frontiers in public health · 2022Article
- Disseminated alveolar echinococcosis in a patient diagnosed by metagenomic next-generation sequencing: A case report.Frontiers in public health · 2022Article
- Prevalence and spatial distribution characteristics of human echinococcosis in China.PLoS neglected tropical diseases · 2021Article
- Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
30 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Both alveolar echinococcosis (AE) and cystic echinococcosis are endemic in China, among which alveolar echinococcosis has a very high mortality rate. The survey results showed the prevalence and scope of AE in China and identified high-risk groups including children, monks, herdsmen and illiterate people. At the same time, all the cases found in the survey (more than 90% of the patients did not go to the hospital for diagnosis and treatment before survey) were promptly diagnosed and treated. This study provides information for the development of a plan for AE prevention and control and for the implementation of interventions targeted to high-risk populations.
Identifiers
34594609PMC8422174What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.